Benzinga··Vandana SinghCatheter Precision Exits Atherectomy Business to Concentrate on EP Platform
Catheter Precision divests atherectomy business for $15M upfront plus equity stake and royalties, refocusing on electrophysiology platform.
VTAKstrategic shiftdivestiture